Predictores de gravedad en pacientes hospitalizados por COVID-19 en el Hospital Integrado Respiratorio del Alto Paraná, 2021
Predictors of severity in patients hospitalized for COVID-19 at the Alto Paraná Integrated Respiratory Hospital, 2021
DOI:
https://doi.org/10.53732/rccsalud/04.01.2022.105Keywords:
COVID-19, inpatients, risk factors, biomarkersAbstract
Introduction. The severity of patients hospitalized for COVID-19 can be determined by its sociodemographic characteristics and underlying diseases, as well as changes in symptoms and laboratory results. Objective. to analyze severity predictors in patients hospitalized for COVID-19 at the Alto Paraná Respiratory Integrated Hospital. Methodology. Observational cros-sectional, retrospective study. Clinical charts of patients hospitalized between January and March of 2021 were retrospectively reviewed. Sociodemographic and clinical characteristics and severity risk factors were analyzed. Results. Of the 137 patients studied, 62.0% (n=85) were male. Mortality was 43.8% (n=60), similar in those under and over 60 years old. ICU admission was associated with higher mortality 69.4% (n=43) (p<0.001). The main symptoms were dyspnea 63.5% (n=87), dry cough 55.47% (n=76) and fever 54.0% (n=74), only dyspnea was associated (p<0.05) to death. The most frequent underlying diseases associated with a higher risk of death (p<0.001) were arterial hypertension, diabetes mellitus and obesity. The most frequently altered laboratory parameters were leukocytosis, neutrophilia, lymphopenia, AST, D-dimer, ferritin and glycemia, but the markers associated (p<0.05) with death were lymphopenia, AST and glycemia. Conclusion. Some severity parameters were identified that contributed to the monitoring of the patient's evolution, which can be useful as predictors in the decisions of health professionals for treatment.
References
World Health Organisation (WHO). WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–92. http://dx.doi.org/10.1038/s41579-018-0118-9
Pérez Abreu MR. Características clínico-epidemiológicas de la COVID-19. Rev haban cien med. 2020;19(2):e_3254. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2020000200005
Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol. 2020;92(10):1902–14. https://doi.org/10.1002/jmv.25884
Gao Y dong, Ding M, Dong X, Zhang J jin, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy Eur J Allergy Clin Immunol. 2021;76(2):428–55. https://doi.org/10.1111/all.14657
World Health Organisation (WHO). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)
Gan J, Li J, Li S, Yang C. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study. Front Public Heal. 2020;8:299. https://doi.org/10.3389/fpubh.2020.00299
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. https://doi.org/10.1007/s00134-020-05991-x
Zhang JJ, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–41. https://doi.org/10.1111/all.14238
Kantri A, Ziati J, Khalis M, Haoudar A, El Aidaoui K, Daoudi Y, et al. Hematological and biochemical abnormalities associated with severe forms of COVID-19: A retrospective single-center study from Morocco. PLoS One. 2021;16(2):1–10. http://dx.doi.org/10.1371/journal.pone.0246295
World Health Organisation (WHO). WHO Coronavirus (COVID-19) Dashboard. 2022. https://covid19.who.int/
Ministerio de Salud Pública y Bienestar Social (Paraguay). Reporte Paraguay MSPBS COVID-19. 2022. https://www.mspbs.gov.py/reportes-covid19.html
Ministerio de Salud Pública y Bienestar Social (Paraguay). COVID-19: aumentan casos de variante Delta. 2021. https://www.mspbs.gov.py/portal/24184/covid-19-aumentan-casos-de-variante-delta.html
Vargas-Correa A, Mereles EF, Segovia Coronel N, Giménez Ayala A, Santacruz L, Ojeda ML, et al. Características clínico-epidemiológicas de pacientes confirmados con COVID-19 del Departamento de Alto Paraná, Paraguay. Rev salud publica del Paraguay. 2021;11(1):54–61. https://doi.org/10.18004/rspp.2021.junio.54
Sobarzo P, Rolón López JC, Narváez Serra PF, López Cañete SA. Características clínicas de los primeros 60 pacientes con SARS CoV-2 internados en el Hospital Nacional periodo junio-agosto 2020. Rev Virtual la Soc Paraguaya Med Interna. 2021;8(1):69–77. https://www.revistaspmi.org.py/index.php/rvspmi/article/view/203
Olivas-Martínez A, Cárdenas-Fragoso JL, Jiménez JV, Lozano-Cruz OA, Ortiz-Brizuela E, Tovar-Méndez VH, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PLoS One. 2021;16(2):1–17. https://doi.org/10.1371/journal.pone.0245772
Montiel D, Torres E, Acosta A, Sobarzo P, Pérez H, Ávalos D, et al. Características clínicas, laboratoriales y predictores de mortalidad de pacientes con COVID-19 internados en el Hospital Nacional. Rev. cient. cienc. salud. 2021;3(1):26–37. https://doi.org/10.53732/rccsalud/03.01.2021.26
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. http://dx.doi.org/10.1016/S0140-6736(20)30566-3
Prat Martorell H. Daño de órganos blanco en hipertensión arterial. Medwave. 2006;6(2). http://dx.doi.org/10.5867/medwave.2006.02.2489
Wu X, Li C, Chen S, Zhang X, Wang F, Shi T, et al. Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan, China. Aging (Albany NY). 2021;13(6):7767–80. https://doi.org/10.18632/aging.202813
Collins-Camones JA, Loyola-Salvatierra FV, Gamarra-Lazo RL, Páucar-Miranda CJ, Cárdenas-Ruiz MG, Grande-Castro N, et al. Pruebas de laboratorio y desenlace clínico en pacientes hospitalizados por la COVID-19. Rev la Soc Peru Med Interna. 2021;34(2):53–60. https://doi.org/10.36393/spmi.v34i2.596
Sánchez Vera N, Saavedra Hernández D, Hidalgo Mesa CJ, Aguila López M, Abreu Gutiérrez G, Herrera González V, et al. Parámetros de laboratorio clínico en pacientes con la COVID-19. Rev Cuba med mil. 2021;50(2):e1171–e1171. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572021000200018
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. http://dx.doi.org/10.1016/S0140-6736(20)30211-7
Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–24. https://doi.org/10.1084/jem.20050828
Chu H, Zhou J, Wong BHY, Li C, Chan JFW, Cheng ZS, et al. Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways. J Infect Dis. 2016;213(6):904–14. https://doi.org/10.1093/infdis/jiv380
Carrasco-Sánchez FJ, López-Carmona MD, Martínez-Marcos FJ, Pérez-Belmonte LM, Hidalgo-Jiménez A, Buonaiuto V, et al. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann Med. 2021;53(1):103–16. https://doi.org/10.1080/07853890.2020.1836566
Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428–30. https://doi.org/10.1016/S2468-1253(20)30057-1
Ali N. Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data. Front Med. 2020;7:1–6. https://doi.org/10.3389/fmed.2020.00458
Ding Z, Li G, Chen L, Shu C, Song J, Wang W, et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol. 2021;74(6):1295–302. https://doi.org/10.1016/j.jhep.2020.12.012